FAPESP

$205 Million Investment Accelerates Construction of the Giant Magellan Telescope

Retrieved on: 
Tuesday, August 2, 2022

PASADENA, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- The Giant Magellan Telescope, the most powerful telescope ever engineered using the worlds largest mirrors, today announced it has secured a $205 million investment from its international consortium to accelerate construction.

Key Points: 
  • PASADENA, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- The Giant Magellan Telescope, the most powerful telescope ever engineered using the worlds largest mirrors, today announced it has secured a $205 million investment from its international consortium to accelerate construction.
  • We are honored to receive this investment in our future, said Dr. Robert Shelton, President of Giant Magellan Telescope.
  • The funding comes after the National Academy of Sciences Astro2020 Decadal Survey evaluated the Giant Magellan Telescope as a core partner of the United States Extremely Large Telescope Program.
  • This latest $205 million investment round positions the Giant Magellan Telescope to be one of the first in a new generation of extremely large telescopes to be constructed.

Blue Water Vaccines Announces Collaboration with Instituto Butantan for the Development of BWV-101, a Universal Influenza Vaccine Candidate

Retrieved on: 
Thursday, May 19, 2022

CINCINNATI, May 19, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. (BWV or Blue Water Vaccines or the Company) a biopharmaceutical company developing vaccines, announces a collaboration with the multidisciplinary Center for R&D in Immunobiologics (CeRDI), an initiative of Instituto Butantan (Butantan).

Key Points: 
  • CINCINNATI, May 19, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. (BWV or Blue Water Vaccines or the Company) a biopharmaceutical company developing vaccines, announces a collaboration with the multidisciplinary Center for R&D in Immunobiologics (CeRDI), an initiative of Instituto Butantan (Butantan).
  • Through this partnership, Butantan, a leading Brazilian producer of immunobiologic products and vaccines, and BWV will develop the universal influenza vaccine candidate, BWV-101, in Brazil.
  • Instituto Butantan was approved for a grant from The State of Sao Paulo Research Foundation (FAPESP) to develop BWVs universal influenza vaccine candidate in Brazil.
  • Blue Water Vaccines is developing a universal influenza vaccine that could potentially provide lifelong protection from influenza, including pandemic strains like the 1918 pandemic and 2009 swine flu.

Weizmann Institute of Science Joins Giant Magellan Telescope, a Top Priority for Science Worldwide

Retrieved on: 
Tuesday, October 19, 2021

On September 14, 2021, the GMTO Corporation welcomed the Weizmann Institute of Science into its international consortium of distinguished universities and research institutions building the Giant Magellan Telescope.

Key Points: 
  • On September 14, 2021, the GMTO Corporation welcomed the Weizmann Institute of Science into its international consortium of distinguished universities and research institutions building the Giant Magellan Telescope.
  • The addition of the Weizmann Institute of Science is a giant win for our international consortium, said Walter Massey, board chair of the GMTO Corporation and former director of the National Science Foundation.
  • The Weizmann Institute of Science is a distinguished multidisciplinary research institution from Israel.
  • Joining the GMTO consortium is a huge leap forward for the Weizmann Institute of Science, said Professor Avishay Gal-Yam, head of the Deloro Center for Space and Optics at the Weizmann Institute.